New drug-eluting stents: technological refinement continues
The arrival of drug-eluting stents (DES) nearly 2 decades ago ignited a revolution in the field of interventional cardiology. The addition of antiproliferative drugs to the stent platform reduced the rate of in-stent restenosis significantly and increased the number of patients that, to this date, h...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
Permanyer
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/626637bdb4554f3cbe5e3a267662bc8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|